国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
5期
609-611
,共3页
刘秀娟%陈江平%梁淑英%陈江谊%吴笑环%蓝有金
劉秀娟%陳江平%樑淑英%陳江誼%吳笑環%藍有金
류수연%진강평%량숙영%진강의%오소배%람유금
谷氨酸脱羧酶抗体%胰岛细胞抗体%糖尿病
穀氨痠脫羧酶抗體%胰島細胞抗體%糖尿病
곡안산탈최매항체%이도세포항체%당뇨병
Glutamic acid decarboxylase antibody%Islet cell antibody%Diabetes mellitus
目的 探讨糖尿病患者谷氨酸脱羧酶抗体( GAD-Ab)的检出率及其对糖尿病分型的诊断价值.方法 采用酶联免疫法检测98例糖尿病患者、20例正常对照者血谷氨酸脱羧酶的抗体水平,统计T1DM组、T2DM非肥胖组、T2DM肥胖组、正常对照组共4组研究对象的谷氨酸脱羧酶抗体的检出率,比较每种抗体各组间的阳性率,另外比较两种抗体同时阳性的比率.结果 ①T1DM组、T2DM非肥胖组、T2DM肥胖组GAD-Ab检出率分别为70.0%、6.3%和5.6%;ICA检出率分别为68%、8.8%、7.2%; GAD-Ab和ICA同时阳性的几率为68%.②糖尿病各组的检出率分别与正常组比较,P<0.01,差异有显著性.③T1DM组的检出率分别与T2DM两组比较,均P<0.05,差异有统计学意义.④T2DM两组间检出率比较,P>0.05,差异无统计学意义.结论 GAD-Ab是1型糖尿病自然病程中β细胞功能损伤的一个指标,对糖尿病预测、分型、指导治疗、判断预后等具有一定的意义.
目的 探討糖尿病患者穀氨痠脫羧酶抗體( GAD-Ab)的檢齣率及其對糖尿病分型的診斷價值.方法 採用酶聯免疫法檢測98例糖尿病患者、20例正常對照者血穀氨痠脫羧酶的抗體水平,統計T1DM組、T2DM非肥胖組、T2DM肥胖組、正常對照組共4組研究對象的穀氨痠脫羧酶抗體的檢齣率,比較每種抗體各組間的暘性率,另外比較兩種抗體同時暘性的比率.結果 ①T1DM組、T2DM非肥胖組、T2DM肥胖組GAD-Ab檢齣率分彆為70.0%、6.3%和5.6%;ICA檢齣率分彆為68%、8.8%、7.2%; GAD-Ab和ICA同時暘性的幾率為68%.②糖尿病各組的檢齣率分彆與正常組比較,P<0.01,差異有顯著性.③T1DM組的檢齣率分彆與T2DM兩組比較,均P<0.05,差異有統計學意義.④T2DM兩組間檢齣率比較,P>0.05,差異無統計學意義.結論 GAD-Ab是1型糖尿病自然病程中β細胞功能損傷的一箇指標,對糖尿病預測、分型、指導治療、判斷預後等具有一定的意義.
목적 탐토당뇨병환자곡안산탈최매항체( GAD-Ab)적검출솔급기대당뇨병분형적진단개치.방법 채용매련면역법검측98례당뇨병환자、20례정상대조자혈곡안산탈최매적항체수평,통계T1DM조、T2DM비비반조、T2DM비반조、정상대조조공4조연구대상적곡안산탈최매항체적검출솔,비교매충항체각조간적양성솔,령외비교량충항체동시양성적비솔.결과 ①T1DM조、T2DM비비반조、T2DM비반조GAD-Ab검출솔분별위70.0%、6.3%화5.6%;ICA검출솔분별위68%、8.8%、7.2%; GAD-Ab화ICA동시양성적궤솔위68%.②당뇨병각조적검출솔분별여정상조비교,P<0.01,차이유현저성.③T1DM조적검출솔분별여T2DM량조비교,균P<0.05,차이유통계학의의.④T2DM량조간검출솔비교,P>0.05,차이무통계학의의.결론 GAD-Ab시1형당뇨병자연병정중β세포공능손상적일개지표,대당뇨병예측、분형、지도치료、판단예후등구유일정적의의.
Objective To investigate the detection rate of glutamic acid decarboxylase ( GAD )antibodies in patients with diabetes and the diagnostic value of the rate for typing diabetes.Methods Levels of GAD antibodies were detected in 98 patients with diabetes and 20 healthy controls by enzymelinked immunosorbent assay.The detection rate was documented in group with T1DM,non-obesity group with T2DM, obesity group with T2DM, and control group.The positive rate of GAD-Ab or ICA was compared among the four group and the GAD-Ab and ICA co-positive rate was also compared.Results The detection rate of GAD-Ab was 70.0% in the group with T1DM,6.3% in the non-obesity group with T2DM,5.6% in the obesity group with T2DM; and that of ICA was 68%,8.8%,and 7.2%,respectively.The detection rate differed significantly between the groups with diabetes and the control group ( P< 0.01 )and between the group with T1DM and the two groups with T2DM ( P < 0.05 ); while it did not differ significantly between the non-obesity group with T2DM and the obesity group with T2DM ( P > 0.05 ).Conclusions Glutamic acid decarboxylase antibody is a marker of β-cell dysfunction in the natural course of type 1 diabetes mellitus.It is of significance in predicting,typing and treating diabetes mellitus,and estimating prognosis.